GBPD002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GBPD002, covering 2022-10-20 to 2022-10-20. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002 [Phase 1, Phase 2]